Related Experiment Video
Updated: Aug 23, 2025
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
8.0K
TREAT: Therapeutic RNAs exploration inspired by artificial intelligence technology
Yufan Luo1,2, Liu Liu1, Zihao He1
1Research Center for Ubiquitous Computing Systems, Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China.
Computational and Structural Biotechnology Journal
|November 2, 2022
Summary
The TREAT platform enables one-stop screening and design of RNA therapeutics, focusing on noncoding RNAs and utilizing AI for complex optimization challenges in drug development.
Area of Science:
- RNA therapeutics
- Computational biology
- Bioinformatics
Background:
- RNA engineering advances therapeutic development.
- Current tools neglect noncoding RNAs and complex optimization for RNA drug design.
- Challenges include immunogenicity, instability, and inefficient production.
Purpose of the Study:
- Introduce TREAT, a platform for noncoding RNA therapeutics.
- Enable comprehensive RNA screening and design.
- Address computational complexity in multi-objective RNA optimization.
Main Methods:
- Integrated 43M+ regulatory relationships from 81 networks.
- Employed graph representation learning with Random Walk Diffusions for target screening.
- Stratified features into local and global for efficient large RNA optimization.
Main Results:
- TREAT incorporates diverse regulatory data and advanced screening algorithms.
- The platform supports design and optimization for large and interfering RNAs.
- Feature stratification significantly reduces computational complexity for RNA design.
Conclusions:
- TREAT is a unified platform for RNA therapeutic screening and design, emphasizing noncoding RNAs.
- It leverages AI and extensive biological networks for innovative therapeutic development.
- The platform accelerates the creation of novel therapeutics for challenging diseases.
Related Concept Videos
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
02:30siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
01:23Types of RNA
64.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.4K
03:21RNA-seq
10.3K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.3K
01:29Microorganisms in Medicine and Therapeutics
185
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
185
01:29Translational Regulation
75
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
75